{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:30:50Z","timestamp":1790353850837,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Renji Hospital, School of Medicine, Shanghai JiaoTong University","award":["RJTJ24-MS-020"],"award-info":[{"award-number":["RJTJ24-MS-020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03611-x","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:52:56Z","timestamp":1752137576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["nCD64 index as a new early predictive biomarker for macrophage activation syndrome in adult-onset still\u2019s disease"],"prefix":"10.1186","volume":"27","author":[{"given":"Tongxin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"3611_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset still\u2019s disease. Nat Rev Rheumatol. 2018;14:603\u201318. https:\/\/doi.org\/10.1038\/s41584-018-0081-x.","journal-title":"Nat Rev Rheumatol"},{"key":"3611_CR2","doi-asserted-by":"publisher","unstructured":"Macovei LA, Burlui A, Bratoiu I, Rezus C, Cardoneanu A, Richter P, et al. Adult-onset Still\u2019s disease\u2014a complex disease, a challenging treatment Int. J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms232112810.","DOI":"10.3390\/ijms232112810"},{"key":"3611_CR3","doi-asserted-by":"publisher","unstructured":"Rao S, Tsang LS-L, Zhao M, Shi W. Lu Adult-onset Still\u2019s disease: a disease at the crossroad of innate immunity and autoimmunity Front. Med. 2022;9. https:\/\/doi.org\/10.3389\/fmed.2022.881431.","DOI":"10.3389\/fmed.2022.881431"},{"issue":"11","key":"3611_CR4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15537\/smj.2016.11.15367","volume":"37","author":"AZ Qureshi","year":"2016","unstructured":"Qureshi AZ, AlSheef M, Qureshi WT, et al. Adult onset still\u2019s disease with dermatopathic lymphadenopathy. Saudi Med J. 2016;37(11):1265\u20137. https:\/\/doi.org\/10.15537\/smj.2016.11.15367.","journal-title":"Saudi Med J"},{"issue":"30","key":"3611_CR5","doi-asserted-by":"publisher","first-page":"e4258","DOI":"10.1097\/MD.0000000000004258","volume":"95","author":"M Gerfaud-Valentin","year":"2016","unstructured":"Gerfaud-Valentin M, Cottin V, Jamilloux Y, Hot A, Gaillard-Coadon A, Durieu I, Broussolle C, Iwaz J, S\u00e8ve P. Parenchymal lung involvement in adult-onset still disease: a STROBE-compliant case series and literature review. Medicine. 2016;95(30):e4258. https:\/\/doi.org\/10.1097\/MD.0000000000004258.","journal-title":"Medicine"},{"issue":"3","key":"3611_CR6","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3892\/etm.2016.3512","volume":"12","author":"XT Xi","year":"2016","unstructured":"Xi XT, Wang MJ, Huang RY, Ding BH. Adult onset still\u2019s disease accompanied by acute respiratory distress syndrome: a case report. Exp Ther Med. 2016;12(3):1817\u201321. https:\/\/doi.org\/10.3892\/etm.2016.3512.","journal-title":"Exp Ther Med"},{"key":"3611_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmcr.2017.07.001","volume":"22","author":"A Guerrieri","year":"2017","unstructured":"Guerrieri A, Angeletti G, Mazzolini M, Bassi I, Nava S. Pulmonary involvement in adult still\u2019s disease: case report and brief review of literature. Respir Med Case Rep. 2017;22:91\u20134. https:\/\/doi.org\/10.1016\/j.rmcr.2017.07.001.","journal-title":"Respir Med Case Rep"},{"key":"3611_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jaad.2021.02.005","volume":"85","author":"Y Ding","year":"2021","unstructured":"Ding Y, Tang S, Li S, Yang C, Liu T, Ying S, Zhu D, Sun C, Chen W, Shi Y, Fang H. Qiao risk of macrophage activation syndrome in patients with adult-onset still\u2019s disease with skin involvement: a retrospective cohort study. J Am Acad Dermatol. 2021;85:1503\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2021.02.005.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3611_CR9","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/j.ijid.2012.07.017","volume":"17","author":"S Li","year":"2013","unstructured":"Li S, Huang X, Chen Z, Zhong H, Peng Q, Deng Y, et al. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis. 2013;17(1):e12\u201323.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"3611_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/ijlh.12545","volume":"38","author":"E de Jong","year":"2016","unstructured":"de Jong E, de Lange DW, Beishuizen A, van de Ven PM, Girbes AR, Huisman A. Neutrophil CD64 expression as a longitudinal biomarker for severe disease and acute infection in critically ill patients. Int J Lab Hematol. 2016;38(5):576\u201384.","journal-title":"Int J Lab Hematol"},{"issue":"8","key":"3611_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.ajem.2019.05.001","volume":"37","author":"Y Song","year":"2019","unstructured":"Song Y, Chen Y, Dong X, Jiang X. Diagnostic value of neutrophil CD64 combined with CRP for neonatal sepsis: a meta-analysis. Am J Emerg Med. 2019;37(8):1571\u20136.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"3611_CR12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12879-022-07725-4","volume":"22","author":"Y Gao","year":"2022","unstructured":"Gao Y, Lin L, Zhao J, Peng X, Li L. Neutrophil CD64 index as a superior indicator for diagnosing, monitoring bacterial infection, and evaluating antibiotic therapy: a case control study. BMC Infect Dis. 2022;22(1):892. https:\/\/doi.org\/10.1186\/s12879-022-07725-4.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"3611_CR13","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.12998\/wjcc.v10.i7.2127","volume":"10","author":"YX Shang","year":"2022","unstructured":"Shang YX, Zheng Z, Wang M, Guo HX, Chen YJ, Wu Y, et al. Diagnostic performance of neutrophil CD64 index, procalcitonin, and C-reactive protein for early sepsis in hematological patients. World J Clin Cases. 2022;10(7):2127\u201337. https:\/\/doi.org\/10.12998\/wjcc.v10.i7.2127.","journal-title":"World J Clin Cases"},{"issue":"5","key":"3611_CR14","first-page":"1601","volume":"30","author":"Y Xu","year":"2022","unstructured":"Xu Y, Dong WM, Lin Y, Guo YT, Liu J, Xu T, et al. The clinical value of neutrophil CD64 index in hematological malignancies with pulmonary infection. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022;30(5):1601\u20136.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"3611_CR15","doi-asserted-by":"publisher","first-page":"905060","DOI":"10.3389\/fimmu.2022.905060","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q, Gao Y, Yang T, Zhou Z, Lin K, Zhang W, Li T, Lu Y, Shao L, Zhang W. nCD64 index as a novel inflammatory indicator for the early prediction of prognosis in infectious and non-infectious inflammatory diseases: an observational study of febrile patients. Front Immunol. 2022;13:905060. https:\/\/doi.org\/10.3389\/fimmu.2022.905060. PMID: 35967346; PMCID: PMC9367970.","journal-title":"Front Immunol"},{"key":"3611_CR16","doi-asserted-by":"publisher","unstructured":"Mahroum N, Mahagna H. Amital Diagnosis and classification of adult Still\u2019s disease J. Autoimmun. 2014;48\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.011.","DOI":"10.1016\/j.jaut.2014.01.011"},{"key":"3611_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"3611_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/cyto.b.21216","volume":"92","author":"U Sack","year":"2017","unstructured":"Sack U. CD64 expression by neutrophil granulocytes. Cytometry B Clin Cytom. 2017;92(3):189\u201391.","journal-title":"Cytometry B Clin Cytom"},{"key":"3611_CR19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","volume":"56","author":"J Bleesing","year":"2007","unstructured":"Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007;56:965\u201371. https:\/\/doi.org\/10.1002\/art.22416.","journal-title":"Arthritis Rheum"},{"key":"3611_CR20","doi-asserted-by":"publisher","unstructured":"Di Benedetto P, Cipriani P, Iacono D, Pantano I, Caso F, Emmi G, Grembiale RD, Cantatore FP, Atzeni F, Perosa F, Scarpa R, Guggino G, Ciccia F, Giacomelli R, Ruscitti P. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still\u2019s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort PLoS One, 15 (2020), Article e0235326, https:\/\/doi.org\/10.1371\/journal.pone.0235326","DOI":"10.1371\/journal.pone.0235326"},{"key":"3611_CR21","doi-asserted-by":"publisher","unstructured":"Komiya A, Matsui T, Nogi S, Iwata K, Futami H, Takaoka H, Arinuma Y, Hashimoto A, Shimada K, Ikenaka T, Nakayama H, Furukawa H, Tohma S. Neutrophil CD64 is upregulated in patients with active adult-onset Still\u2019s disease. Scand J Rheumatol. 2012;41(2):156-8. https:\/\/doi.org\/10.3109\/03009742.2011.644325. PMID: 22420333.","DOI":"10.3109\/03009742.2011.644325"},{"key":"3611_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-023-00600-x","author":"S Adachi","year":"2023","unstructured":"Adachi S, Takase-Minegishi K, Maeda A, Nagai H, Horita N, Yoshimi R, Kirino Y, Nakajima H. Risk of macrophage activation syndrome in patients with adult-onset still\u2019s disease treated with IL-1 and IL-6 inhibitors: a meta-analysis and single-center experience. Rheumatol Therapy. 2023. https:\/\/doi.org\/10.1007\/s40744-023-00600-x.","journal-title":"Rheumatol Therapy"},{"key":"3611_CR23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/ard-2023-224123","volume":"82","author":"B Shakoory","year":"2023","unstructured":"Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, et al. The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS) ann. Rheum Dis. 2023;82:1271\u201385. https:\/\/doi.org\/10.1136\/ard-2023-224123.","journal-title":"Rheum Dis"},{"key":"3611_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","volume":"10","author":"E Karakike","year":"2019","unstructured":"Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: A distinct entity leading to early death in sepsis. Front Immunol. 2019;10:55. https:\/\/doi.org\/10.3389\/fimmu.2019.00055.","journal-title":"Front Immunol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03611-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03611-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03611-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T03:56:03Z","timestamp":1757217363000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03611-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3611"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03611-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants according to the recommendations of the Declaration of Helsinki. This study was approved by the institutional review board of Renji Hospital (approval number 2016-083).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}